Jazz Pharmaceuticals plc Increase (Decrease) in Other Operating Liabilities
Jazz Pharmaceuticals plc (JAZZ) reported Increase (Decrease) in Other Operating Liabilities of -$11.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-03
- Jazz Pharmaceuticals plc increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$23.80M.
- Jazz Pharmaceuticals plc increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $12.20M, a 320.69% increase year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in other operating liabilities for the quarter ending 2025-06-30 was -$1.00M.
- Jazz Pharmaceuticals plc increase (decrease) in other operating liabilities for the quarter ending 2025-03-31 was $2.90M.
- Jazz Pharmaceuticals plc increase (decrease) in other operating liabilities for fiscal 2025 was $28.02M.
- Jazz Pharmaceuticals plc increase (decrease) in other operating liabilities for fiscal 2024 was -$39.27M.
- Jazz Pharmaceuticals plc increase (decrease) in other operating liabilities for fiscal 2023 was -$23.60M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|
| 2026-06-30 | -$23.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$11.60M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $12.20M 10-Q · filed 2026-05-05 | ||
| 2025-12-31 | $28.02M 10-K · filed 2026-02-24 | ||
| 2025-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.90M 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $2.90M 10-Q · filed 2026-05-05 | ||
| 2024-12-31 | -$39.27M 10-K · filed 2026-02-24 | ||
| 2023-12-31 | -$23.60M 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |